Add group to favorites
Back to post list
Send new message to group Search:
Post Subject:
FDA Approves Generic FOSAMAX to Treat Osteoporosis
FDA Approves Generic FOSAMAX to Treat Osteoporosis
The U.S. Food and Drug Administration today approved the first generic
versions of Fosamax (alendronate sodium tablets), used to treat
osteoporosis, a condition that causes thinning and weakening of a
person's bones.
Teva Pharmaceuticals USA, North Wales, Pa., was approved to
manufacture alendronate sodium tablets in three once-daily dosing
strengths (5 milligrams, 10 milligrams, and 40 milligrams) and two
once-weekly dosing strengths (35 milligrams and 70 milligrams). Barr
Laboratories, Inc., Montvale, N.J., was approved to manufacture a 70
milligrams once-weekly dose of the drug......
* fosamaxhealth.blogspot . com /2008/02/generic-fosamax-approved.html
The U.S. Food and Drug Administration today approved the first generic
versions of Fosamax (alendronate sodium tablets), used to treat
osteoporosis, a condition that causes thinning and weakening of a
person's bones.
Teva Pharmaceuticals USA, North Wales, Pa., was approved to
manufacture alendronate sodium tablets in three once-daily dosing
strengths (5 milligrams, 10 milligrams, and 40 milligrams) and two
once-weekly dosing strengths (35 milligrams and 70 milligrams). Barr
Laboratories, Inc., Montvale, N.J., was approved to manufacture a 70
milligrams once-weekly dose of the drug......
* fosamaxhealth.blogspot . com /2008/02/generic-fosamax-approved.html
Next: World Pharma News Digest - 25.02.2008
Previous: Japan successfully launches high-speed Internet satellite...
